| CTRI Number |
CTRI/2026/01/101782 [Registered on: 22/01/2026] Trial Registered Prospectively |
| Last Modified On: |
21/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Follow Up Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A study to understand how homoeopathic treatment can be used to give comfort, relief and better quality of life to patients with advanced cancer, by developing clear guidelines based on real patient cases. |
|
Scientific Title of Study
|
Evolving the parameters for deciding palliative approach with homoeopathy in advance cases of cancer - a case series study. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sonia Kasturilal Jawalia |
| Designation |
MD Part 2 |
| Affiliation |
Dr M L Dhawale Memorial Trust Institute |
| Address |
322 Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
322 Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Thane
MAHARASHTRA
401404
India |
| Phone |
7045250109 |
| Fax |
|
| Email |
jawaliasonia@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Mehvish Haris Dandoti |
| Designation |
Guide, Associate Professor |
| Affiliation |
Dr M L Dhawale Memorial Trust Institute |
| Address |
322 Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
322 Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Thane
MAHARASHTRA
401404
India |
| Phone |
7738403423 |
| Fax |
|
| Email |
mehvish0027@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Dr Mehvish Haris Dandoti |
| Designation |
Associated Professor |
| Affiliation |
Dr M L Dhawale Memorial Trust Institute |
| Address |
Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Thane
MAHARASHTRA
401404
India |
| Phone |
7738403423 |
| Fax |
|
| Email |
mehvish0027@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr M L Dhawale Memorial Trust Institute Palghar |
|
|
Primary Sponsor
|
| Name |
Dr M L Dhawale Memorial Trust Institute Palghar |
| Address |
Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp S T Workshop Palghar Taluka Industrial cooperative Estate Palghar Thane Maharashtra |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sonia Kasturilal Jawalia |
Dr M L Dhawale Memorial Trust Institute |
Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Department of Organon of Medicine and Homoeopathic Philosophy Dr M L Dhawale Memorial Trust Institute Boisar Rd Opp ST Workshop Palghar Taluka Industrial Cooperative Estate Palghar
Thane
MAHARASHTRA |
07045250109
jawaliasonia@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, MLDMHI, Palghae |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
All cases above 18 years of age
All cases of all types of cancers of advance stage-3rd and
4th identified according to TNM staging.
All patients diagnosed with some type of cancer according
to histopathological findings.
All patients who are being managed according to the
conventional management i.e anti-cancer medicines
available in form of chemotherapy/surgery/
radiotherapy.
All patients who have refused to take conventional
treatment or anti-cancer medicines or surgery or
radiotherapy.
All patients who were refused/advised against taking
conventional treatment or anti-cancer medicines or
surgery or radiotherapy.
All patients who were willing for homoeopathy as an
adjuvant to the ongoing treatment or Homoeopathy as a
stand alone management for minimum of 1 week to a
maximum of 8 weeks.
All patient who agree to be observed for a period of 1
week to 8 weeks for this study and who allow their data to
be used for this study. |
|
| ExclusionCriteria |
| Details |
Patients are not willing to undergo homoeopathic
treatment.
Patients taking treatment for less than 1 week.
Incomplete data or assessment between pre and post
assessment.
Patients not willing to give their data for observation and
assessment for this study.
Patients with cancer in situ, stage 1 and stage 2.
All patient who require immediate emergency
management in form of life support- ventilators etc. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
To evolve the parameters for deciding the palliative approach in advanced
cases of cancer. |
8 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| none |
none |
|
|
Target Sample Size
|
Total Sample Size="45"
Sample Size from India="45"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/02/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Evolving the parameters for deciding palliative approach with homoeopathy in advance cases of cancer - a case series study. Finding ways to decide how homoeopathy can best give comfort and relief to people with advanced cases of cancer - based on real patient cases. To evolve the parameters for deciding the palliative approach in advanced |